Chang‐Jun Tan
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Liver Disease and Transplantation
- Transplantation top 10%
Papers in
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Liver physiology and pathology 3
-
- Circular RNAs in diseases 2
- Co-authors
- Jia Fan (16 shared papers)Jian Zhou (7 shared papers)Jian Zhou (12 shared papers)Xiao‐Dong Zhu (8 shared papers)Ying‐Hao Shen (8 shared papers)Cheng Huang (7 shared papers)Hui‐Chuan Sun (8 shared papers)Ningling Ge (5 shared papers)
In The Last Decade
Chang‐Jun Tan
28 papers receiving 677 citations
Chang‐Jun Tan's Hit Papers
Peers
Comparison fields: 5 of 69
- Hepatology 294
- Transplantation 20
- Cancer Research 106
- Oncology 88
- Pathology and Forensic Medicine 54
Countries citing papers authored by Chang‐Jun Tan
This map shows the geographic impact of Chang‐Jun Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Jun Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Jun Tan more than expected).
Fields of papers citing papers by Chang‐Jun Tan
This network shows the impact of papers produced by Chang‐Jun Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Jun Tan. The network helps show where Chang‐Jun Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang‐Jun Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations Hit paper breakdown → | 2021 | 166 |
| 2 | 2013 | 59 | |
| 3 | 2012 | 54 | |
| 4 | 2021 | 50 | |
| 5 | 2008 | 48 | |
| 6 | 2014 | 45 | |
| 7 | 2008 | 30 | |
| 8 | 2015 | 29 | |
| 9 | Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. | 2006 | 24 |
| 10 | 2009 | 22 | |
| 11 | 2013 | 20 | |
| 12 | 2007 | 20 | |
| 13 | 2002 | 17 | |
| 14 | 2020 | 13 | |
| 15 | 2012 | 12 | |
| 16 | 2011 | 11 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2017 | 9 | |
| 20 | 2020 | 8 |
About Chang‐Jun Tan
Chang‐Jun Tan is a scholar working on Hepatology, Molecular Biology, Oncology, Surgery and Immunology, having authored 30 papers that have together received 683 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver physiology and pathology (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ferroptosis and cancer prognosis (2 papers), Circular RNAs in diseases (2 papers), Cancer Research and Treatments (2 papers), Transplantation: Methods and Outcomes (2 papers) and Genetic Mapping and Diversity in Plants and Animals (2 papers). The work is most often cited by research in Hepatology (294 citations), Transplantation (20 citations), Cancer Research (106 citations), Oncology (88 citations) and Pathology and Forensic Medicine (54 citations). Chang‐Jun Tan has collaborated with scholars based in China, Norway and Germany. Frequent co-authors include Jia Fan, Jian Zhou, Jian Zhou, Xiao‐Dong Zhu, Ying‐Hao Shen, Cheng Huang, Hui‐Chuan Sun, Ningling Ge, Yuan Ji and Zhao–You Tang. Their work appears in journals such as Journal of Clinical Oncology, Expert Opinion on Investigational Drugs, Liver Cancer, Cancer Medicine and Transplant Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.